Ameriprise Financial Inc Dynavax Technologies Corp Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 413,278 shares of DVAX stock, worth $5.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
413,278
Previous 450,740 8.31%
Holding current value
$5.31 Million
Previous $5.06 Million 9.05%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$10.05 - $11.61 $376,493 - $434,933
-37,462 Reduced 8.31%
413,278 $4.6 Million
Q2 2024

Aug 14, 2024
SELL
$10.73 - $12.58 $135,637 - $159,023
-12,641 Reduced 2.73%
450,740 $5.06 Million
Q1 2024

May 15, 2024
BUY
$11.7 - $14.98 $847,044 - $1.08 Million
72,397 Added 18.52%
463,381 $5.75 Million
Q4 2023

Feb 14, 2024
SELL
$13.09 - $14.98 $338,939 - $387,877
-25,893 Reduced 6.21%
390,984 $5.47 Million
Q3 2023

Nov 14, 2023
SELL
$12.64 - $14.99 $119,839 - $142,120
-9,481 Reduced 2.22%
416,877 $6.16 Million
Q2 2023

Aug 14, 2023
SELL
$9.85 - $13.17 $134,225 - $179,467
-13,627 Reduced 3.1%
426,358 $5.51 Million
Q1 2023

May 15, 2023
SELL
$9.44 - $11.88 $213,957 - $269,260
-22,665 Reduced 4.9%
439,985 $4.32 Million
Q4 2022

Feb 14, 2023
SELL
$10.27 - $13.29 $191,689 - $248,057
-18,665 Reduced 3.88%
462,650 $4.92 Million
Q3 2022

Nov 14, 2022
SELL
$9.93 - $17.44 $194,201 - $341,074
-19,557 Reduced 3.9%
481,315 $5.03 Million
Q2 2022

Aug 15, 2022
BUY
$7.45 - $12.83 $3.73 Million - $6.43 Million
500,872 New
500,872 $6.31 Million
Q1 2022

May 16, 2022
SELL
$9.75 - $14.44 $206,758 - $306,214
-21,206 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$13.17 - $20.94 $64,098 - $101,914
-4,867 Reduced 18.67%
21,206 $298,000
Q3 2021

Nov 15, 2021
SELL
$9.16 - $19.83 $69,441 - $150,331
-7,581 Reduced 22.53%
26,073 $501,000
Q2 2021

Aug 16, 2021
BUY
$7.25 - $10.99 $5,930 - $8,989
818 Added 2.49%
33,654 $333,000
Q1 2021

May 17, 2021
SELL
$4.57 - $11.18 $5.87 Million - $14.4 Million
-1,283,960 Reduced 97.51%
32,836 $323,000
Q4 2020

Feb 12, 2021
SELL
$3.73 - $5.6 $2.94 Million - $4.42 Million
-788,572 Reduced 37.46%
1,316,796 $5.85 Million
Q3 2020

Nov 16, 2020
BUY
$4.32 - $11.7 $3.82 Million - $10.4 Million
885,052 Added 72.53%
2,105,368 $9.08 Million
Q2 2020

Aug 14, 2020
BUY
$2.94 - $9.1 $3.28 Million - $10.2 Million
1,115,439 Added 1063.57%
1,220,316 $10.8 Million
Q1 2020

May 15, 2020
SELL
$2.27 - $6.2 $1.59 Million - $4.35 Million
-701,616 Reduced 87.0%
104,877 $369,000
Q4 2019

Feb 14, 2020
BUY
$3.46 - $6.93 $818,501 - $1.64 Million
236,561 Added 41.51%
806,493 $4.61 Million
Q3 2019

Nov 14, 2019
SELL
$2.69 - $4.85 $1.28 Million - $2.31 Million
-476,490 Reduced 45.54%
569,932 $2.04 Million
Q2 2019

Aug 14, 2019
BUY
$3.65 - $7.89 $1.14 Million - $2.46 Million
312,090 Added 42.5%
1,046,422 $4.18 Million
Q1 2019

May 15, 2019
BUY
$7.08 - $12.09 $1.08 Million - $1.85 Million
153,039 Added 26.33%
734,332 $5.37 Million
Q4 2018

Feb 14, 2019
BUY
$8.14 - $13.28 $743,426 - $1.21 Million
91,330 Added 18.64%
581,293 $5.32 Million
Q3 2018

Nov 14, 2018
BUY
$11.85 - $16.0 $1.32 Million - $1.79 Million
111,780 Added 29.56%
489,963 $6.08 Million
Q2 2018

Aug 14, 2018
SELL
$15.15 - $20.75 $965,933 - $1.32 Million
-63,758 Reduced 14.43%
378,183 $5.77 Million
Q1 2018

May 15, 2018
SELL
$14.65 - $19.9 $62,892 - $85,430
-4,293 Reduced 0.96%
441,941 $8.77 Million
Q4 2017

Feb 12, 2018
SELL
$17.3 - $24.08 $2.63 Million - $3.65 Million
-151,756 Reduced 25.38%
446,234 $8.35 Million
Q3 2017

Nov 07, 2017
BUY
$15.2 - $21.5 $9.09 Million - $12.9 Million
597,990
597,990 $12.9 Million

Others Institutions Holding DVAX

# of Institutions
276
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.63B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email